" class="no-js "lang="en-US"> GSK Archives - Medtech Alert
Saturday, March 25, 2023

Sort by:


Top Post

China National Medical Products Administration Accepts Regulatory Submission for Nucala (mepolizumab) in Severe Eosinophilic Asthma

GSK today announced that the China National Medical Products Administration has accepted for review a […]

ViiV Healthcare announces positive data demonstrating long-acting injectable Cabenuva is as effective as daily oral Biktarvy for the treatment of HIV-1

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi […]

U.S. FDA Grants Regular Approval for Jemperli for the Treatment of Patients with Recurrent or Advanced Mismatch Repair-deficient Endometrial Cancer

GSK reports that the US Food and Drug Administration (FDA) granted full approval for Jemperli (dostarlimab-gxly) […]

Jesduvroq Approved by US FDA for Anaemia of Chronic Kidney Disease in Adults on Dialysis

GSK today announced that the US Food and Drug Administration (FDA) has approved Jesduvroq (daprodustat), […]

GSK Completes Acquisition of Sierra Oncology

GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Sierra Oncology, Inc. […]

GSK Announces £1 Billion R&D Investment Over Ten Years to Get Ahead of Infectious Diseases in Lower-income Countries

GSK plc (LSE/NYSE: GSK) announced today an investment of £1bn over ten years to accelerate […]

GSK Presents Promising New Data for Bepirovirsen, an Investigational Treatment for Chronic Hepatitis B

GSK plc today announced promising interim results from the B-Clear phase IIb trial showing that […]

GSK to Acquire Clinical-stage Biopharmaceutical Company Affinivax, Inc.

GSK plc (LSE/NYSE: GSK) today announced that it has entered into a definitive agreement to […]

GSK Announces Further Appointments to Designate Haleon Board

GSK plc (LSE/NYSE: GSK) has today announced the appointments of Asmita Dubey, Marie-Anne Aymerich and […]

GSK Announces Dr Vishal Sikka to Join the Board as Non-executive Director

GlaxoSmithKline plc (LSE/NYSE: GSK) has today announced that Dr Vishal Sikka, founder and CEO of […]

  1. Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Read more
  2. Celyad Oncology Appoints Georges Rawadi as Its New CEO Read more
  3. Companion Spine Closes $60.1 Million Series A Funding Round Read more
  4. EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Read more
  5. Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer Read more